Effect of thermal dose on heat shock protein expression after radio-frequency ablation with and without adjuvant nanoparticle chemotherapies

References

• Kim YS, Lim HK, Rhim H, Lee MW. Ablation of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2014;28:897–908.
   PubMed Web of Science ®Google Scholar
• Fornage BD, Hwang RF. Current status of imaging-guided percutaneous ablation of breast cancer. Am J Roentgenol 2014;203:442–8.
   PubMed Web of Science ®Google Scholar
• De Filippo M, Bozzetti F, Martora R, Zagaria R, Ferretti S, Macarini L, et al. Radiofrequency thermal ablation of renal tumors. Radiol Med 2014;119:499–511.
   PubMed Web of Science ®Google Scholar
• Salapura V, Jeromel M. Minimally invasive (percutaneous) treatment of metastatic spinal and extraspinal disease – a review. Acta Clin Croat 2014;53:44–54.
   PubMed Web of Science ®Google Scholar
• Mirza AN, Fornage BD, Sneige N, Kuerer HM, Newman LA, Ames FC, et al. Radiofrequency ablation of solid tumors. Cancer J 2001;7:95–102.
   PubMed Web of Science ®Google Scholar
• Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology. 2004;127(6):1714–23.
   PubMed Web of Science ®Google Scholar
• Stang A, Fischbach R, Teichmann W, Bokemeyer C, Braumann D. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 2009;45:1748–56.
   PubMed Web of Science ®Google Scholar
• Alexander ES, Machan JT, Ng T, Breen LD, DiPetrillo TA, Dupuy DE. Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage I non-small-cell lung cancer in elderly patients: is less more? J Vasc Interv Radiol 2013;24:476–82.
   PubMed Web of Science ®Google Scholar
• Solbiati L, Ahmed M, Cova L, Ierace T, Brioschi M, Goldberg SN. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology 2012;265:958–68.
   PubMed Web of Science ®Google Scholar
• Lai EC, Tang CN. Radiofrequency ablation versus hepatic resection for hepatocellular carcinoma within the Milan criteria – a comparative study. Int J Surg 2013;11:77–80.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ, et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 2013;58:89–97.
   PubMed Web of Science ®Google Scholar
• Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005;242:158–71.
   PubMed Web of Science ®Google Scholar
• Kruskal JB, Oliver B, Huertas JC, Goldberg SN. Dynamic intrahepatic flow and cellular alterations during radiofrequency ablation of liver tissue in mice. J Vasc Interv Radiol 2001;12:1193–201.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Kamel IR, Kruskal JB, Reynolds K, Monsky WL, Stuart KE, et al. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. Am J Roentgenol 2002;179:93–101.
   PubMed Web of Science ®Google Scholar
• Solazzo SA, Ahmed M, Schor-Bardach R, Yang W, Girnun GD, Rahmanuddin S, et al. Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways. Radiology 2010;255:62–74.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Liu Z, Lukyanov AN, Signoretti S, Horkan C, Monsky WL, et al. Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals. Radiology 2005;235:469–77.
   PubMed Web of Science ®Google Scholar
• Soundararajan A, Dodd GD III, Bao A, Phillips WT, McManus LM, Prihoda TJ, et al. Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model. Radiology 2011;261:813–23.
   PubMed Web of Science ®Google Scholar
• Yang W, Ahmed M, Tasawwar B, Levchenko T, Sawant RR, Collins M, et al. Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model. Int J Hyperthermia 2011;27:527–38.
   PubMed Web of Science ®Google Scholar
• Yang W, Ahmed M, Tasawwar B, Levchenko T, Sawant RR, Torchilin V, et al. Combination radiofrequency (RF) ablation and intravenous liposomal heat shock protein suppression: reduced tumor growth and increased animal endpoint survival in a small animal tumor model. J Control Release 2012;160:239–44.
   PubMed Web of Science ®Google Scholar
• Mertyna P, Dewhirst MW, Halpern E, Goldberg W, Goldberg SN. Radiofrequency ablation: the effect of distance and baseline temperature on thermal dose required for coagulation. Int J Hyperthermia 2008;24:550–9.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol 1995;2:399–404.
   PubMed Web of Science ®Google Scholar
• Poon, RTP. Phase 3, randomized, double-blind, dummy-controlled, trial of radiofrequency ablation (RFA) + lyso-thermosensitive liposomal doxorubicin (LTLD, Thermodox®) for hepatocellular carcinoma (HCC) lesions 3-7Cm. Abstract presented at the International Liver Cancer Association Seventh Annual Conference, September 2013.
   Google Scholar
• Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984;10:787–800.
   PubMed Web of Science ®Google Scholar
• Chen T, Guo J, Han C, Yang M, Cao X. Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway. J Immunol 2009;182:1449–59.
   PubMed Web of Science ®Google Scholar
• Yuan H, Schroeder T, Bowsher JE, Hedlund LW, Wong T, Dewhirst MW. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med 2006;47:989–98.
   PubMed Web of Science ®Google Scholar
• van Rhoon GC, Samaras T, Yarmolenko PS, Dewhirst MW, Neufeld E, Kuster N. CEM43 degrees C thermal dose thresholds: a potential guide for magnetic resonance radiofrequency exposure levels? Eur Radiol 2013;23:2215–27.
   PubMed Web of Science ®Google Scholar
• Chang IA. Considerations for thermal injury analysis for RF ablation devices. Open Biomed Eng J 2010;4:3–12.
   PubMedGoogle Scholar
• Scudamore CH, Lee SI, Patterson EJ, Buczkowski AK, July LV, Chung SW, et al. Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg 1999;177:411–17.
   PubMed Web of Science ®Google Scholar
• Baust JG, Gage AA, Klossner D, Clarke D, Miller R, Cohen J, et al. Issues critical to the successful application of cryosurgical ablation of the prostate. Technol Cancer Res Treat 2007;6:97–109.
   PubMed Web of Science ®Google Scholar
• Hernandez JI, Cepeda MF, Valdes F, Guerrero GD. Microwave ablation: state-of-the-art review. Onco Targets Ther 2015;8:1627–32.
   PubMed Web of Science ®Google Scholar
• Quaranta V, Manenti G, Bolacchi F, Cossu E, Pistolese CA, Buonomo OC, et al. FEM analysis of RF breast ablation: multiprobe versus cool-tip electrode. Anticancer Res 2007;27:775–84.
   PubMed Web of Science ®Google Scholar
• Solazzo SA, Ahmed M, Schor-Bardach R, Yang W, Girnun GD, Rahmanuddin S, et al. Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways. Radiology 2010;255:62–74.
   PubMed Web of Science ®Google Scholar
• Kruskal JB, Oliver B, Huertas JC, Goldberg SN. Dynamic intrahepatic flow and cellular alterations during radiofrequency ablation of liver tissue in mice. J Vasc Intervent Radiol 2001;12:1193–201.
   PubMed Web of Science ®Google Scholar
• Cabibbo G, Latteri F, Antonucci M, Craxi A. Multimodal approaches to the treatment of hepatocellular carcinoma. Nature Clin Pract Gastroenterol Hepatol 2009;6:159–69.
   PubMedGoogle Scholar
• Hoffmann RT, Jakobs TF, Kubisch CH, Stemmler HJ, Trumm C, Tatsch K, et al. Radiofrequency ablation after selective internal radiation therapy with yttrium90 microspheres in metastatic liver disease – is it feasible? Eur J Radiol 2010;74:199–205.
   PubMed Web of Science ®Google Scholar
• Horkan C, Dalal K, Coderre JA, Kiger JL, Dupuy DE, Signoretti S, et al. Reduced tumor growth with combined radiofrequency ablation and radiation therapy in a rat breast tumor model. Radiology 2005;235:81–8.
   PubMed Web of Science ®Google Scholar
• Shiozawa K, Watanabe M, Takahashi M, Wakui N, Iida K, Sumino Y. Analysis of patients with rapid aggressive tumor progression of hepatocellular carcinoma after percutaneous radiofrequency ablation. Hepatogastroenterology 2009;56:1689–5.
   PubMed Web of Science ®Google Scholar
• Nijkamp MW, Borren A, Govaert KM, Hoogwater FJ, Molenaar IQ, van Diest PJ, et al. Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth. J Surgl Oncol 2010;101:551–6.
   PubMed Web of Science ®Google Scholar
• Yarmolenko PS, Moon EJ, Landon C, Manzoor A, Hochman DW, Viglianti BL, et al. Thresholds for thermal damage to normal tissues: An update. Int J Hyperthermia 2011;27:320–43.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Liu Z, Afzal KS, Weeks D, Lobo SM, Kruskal JB, et al. Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 2004;230:761–7.
   PubMed Web of Science ®Google Scholar
• Brown SL, Hunt JW, Hill RP. Differential thermal sensitivity of tumour and normal tissue microvascular response during hyperthermia. Int J Hyperthermia 1992;8:501–14.
   PubMed Web of Science ®Google Scholar
• Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005;242:158–71.
   PubMed Web of Science ®Google Scholar
• Thrall DE, Rosner GL, Azuma C, Larue SM, Case BC, Samulski T, et al. Using units of CEM43 °C T90, local hyperthermia thermal dose can be delivered as prescribed. Int J Hyperthermia 2000;16:415–28.
   PubMed Web of Science ®Google Scholar
• Yarmolenko PS, Moon EJ, Landon C, Manzoor A, Hochman DW, Viglianti BL, et al. Thresholds for thermal damage to normal tissues: an update. Int J Hyperthermia 2011;27:320–43.
   PubMed Web of Science ®Google Scholar